Although AOM liraglutide (Saxenda) has been approved for treatment of obesity in adolescents since late 2020 ( 5 ), the approval of AOM semaglutide (Wegovy) in December 2022 for treatment of obesity for adolescents prompted new excitement ( 6 )
RETA Retatrutide investigated in metabolic and weight-regulation research models
This region has the lowest levels of vitamin C in the brain, a major topic due to the relationship that has been established between oxidative stress and Parkinson's disease
Frequently Asked Questions Yes, but in moderation
He highlighted three key advantages of semaglutide in diabetes care: reduced risk of hypoglycemia or low blood sugar levels compared to traditional therapies, strong HbA1c reduction, and benefits related to weight and organ protection
#TypeOneDiabetes #Diabetes #Endocrinology #ADA2026 #InsulinTherapy #Medigear To view or add a comment, sign in 5,237 followers More from this author The American College of Medical Quality announces a "New Day"
/assets/images/provider/photos/2798511.png)
